Evidence-Based Respiratory Medicine

• First major evidence-based text in adult respiratory medicine
• Comprehensive, authoritative summary of the best treatments for the major respiratory diseases
• Compiled by specialists from the Cochrane Airways Management Group
• Easy-to-use format, with key clinical implications summarised in each chapter
• Kept up-to-date online

Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine.

Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world's leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter.

Evidence-based Respiratory Medicine tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient's needs.

Evidence-Based Series: Evidence-based Respiratory Medicine, part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text.

Note: CD-ROM/DVD and other supplementary materials are not included as part of eBook file.

Acknowledgement to Cochrane Library.

1 Practising evidence-based respiratory medicine.

1.1 Introduction.

1.2 Diagnostic strategies.

1.2.1 Presenting symptoms.

1.2.2 Lung function testing.

1.2.3 Chest radiographic and CT patterns.

1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach.

1.2.5 Screening for lung cancer.

1.3 Therapeutics: general issues.

1.3.1 Adherence and self-management.

1.3.2 Corticosteroid-induced osteoporosis.

1.3.3 Helping people to stop smoking.

2 Asthma.

2.1 Acute exacerbations.

2.2 Chronic therapy: beta-agonists – short-acting, long-acting beta2-agonists.

2.3 Inhaled corticosteroids in the treatment of asthma.

2.4 Anti-leukotrienes.

2.5 Asthma education.

.2.6 Non-pharmacological and complementary interventions to manage asthma.

2.7 Difficult asthma.

2.8 Novel therapies in asthma: long-acting beta2-agonists/inhaled corticosteroids.

3 Chronic obstructive pulmonary disease.

3.1 Chronic obstructive pulmonary disease – acute exacerbations.

3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy.

3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease.

3.4 Combination of inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease.

3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease.

3.6 Lung volume reduction.

4 Infection.

4.1 Bronchitis and sinusitis.

4.2 Community-acquired pneumonia.

4.3 Pulmonary tuberculosis.

4.4 Influenza: vaccination and treatment.

4.5 Bronchiectasis.

4.6 Adult cystic fibrosis.

4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis.

5 Respiratory failure/sleep disordered breathing.

5.1 Respiratory rehabilitation.

5.2 Non-invasive ventilation in acute respiratory failure.

5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?

5.4 The treatment of the obstructive sleep apnoea–hypopnoea syndrome.

5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease.

6 Diffuse lung disease / pleural disease / thromboembolism.

6.1 Diffuse lung disease.

6.1.1 The treatment of cryptogenic fibrosing alveolitis.

6.1.2 Evidence-based approach to treatment of sarcoidosis.

6.1.3 Hypersensitivity pneumonitis.

6.2 Pleural disease.

6.3 Therapy of pulmonary thromboembolism: an evidence-based approach.

6.4 Pulmonary hypertension.

Index.